Endocrine Cancer Treatment At The James - John Phay, Md

Endocrine Cancer Treatment at The James – John Phay, MD

Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute

Why John Phay, MD, Chose to Work at the OSUCCC – James

Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute

Thyroid Cancer Myths – John Phay, MD

Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute

Meet John Phay, MD, Surgical Oncologist at the OSUCCC – James

Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute

Meet John Phay, MD, Surgical Oncologist at the OSUCCC – James

Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute

Endocrine and Oncologic Surgeon John T. Miura, MD

Emerging Therapies in Neuroendocrine Tumors (NETs)

What is the difference between chemo and hormonal therapy? (John Charlson, MD)

Froedtert & the Medical College of Wisconsin

Race and Pancreatic Neuroendocrine Tumors | JACS Talking Points | ACS

American College of Surgeons

Medicine for members: Neuroendocrine tumours - the quiet cancer

Royal Free London NHS Foundation Trust

Surgery for Neuroendocrine Tumors

Carcinoid Cancer Foundation

Presidential Address

AAES

Treating ER+ breast cancer patients with endocrine therapy resistance

Dr. Dadu on Treatment Options for Thyroid Cancer

Adjuvant endocrine therapy for breast cancer: optimal durations and regimens

NET treatment and management: an update

Royal Free London NHS Foundation Trust

The James at Ohio State study helping change ovarian cancer treatment options

Dr. Thomas J. Fahey, III - Endocrine Oncology Program

Decisions Regarding Resectability and Neoadjuvant Therapy in PNETs

Getting a Second Opinion for Your Thyroid Cancer | UCLA Endocrine Center